Seroprevalence of IgG antibodies against tetanus toxoid among different age groups in Poland
Vaccination is the most effective and reliable strategy for preventing the morbidity of tetanus. The aim of the study is to investigate the seroprevalence of antibodies to tetanus toxoid among healthy persons across all age groups to determine the level of vaccine-induced immunity in the population,...
Saved in:
Published in | Annals of Agricultural and Environmental Medicine Vol. 31; no. 3; pp. 329 - 333 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Poland
25.09.2024
|
Subjects | |
Online Access | Get full text |
ISSN | 1232-1966 1898-2263 1898-2263 |
DOI | 10.26444/aaem/182987 |
Cover
Loading…
Abstract | Vaccination is the most effective and reliable strategy for preventing the morbidity of tetanus. The aim of the study is to investigate the seroprevalence of antibodies to tetanus toxoid among healthy persons across all age groups to determine the level of vaccine-induced immunity in the population, and to identify which age group should be targeted for a booster dose.
A total of 2,842 serum samples collected between 2010 - 2019 from individuals aged from 1 month - 97 years were investigated. Anti-tetanus IgG antibody concentrations (IU/ml) were measured by an enzyme-linked immunosorbent assay. In addition, the avidity of antibodies was determined using an in-house ELISA.
The results showed that among the 2,842 individuals, 147 (5.2%) had anti-tetanus toxoid IgG antibody levels below 0.1 IU/ml and another 1,519 (53.4%) subjects showed only basic protection (0.1-1.0 IU/ml) and needed immediate booster. High levels of anti-tetanus toxoid IgG antibodies (>1.0 IU/ml) were found more often in young adults at the age 21-40 years (55.5%, GMT=1.15). Importantly, these antibodies also had the highest avidity. With age, the percentage of high positives decreased, as well as the geometric mean and avidity of antibodies, reaching the lowest level in subjects over 70 years of age (13.3%; GMT=0.19). Characteristically, a higher percentage of high positive results was observed in men (42.6%) than in women (34.3%).
The study showed adequate immunity levels to tetanus amongst the Polish population, especially in children, adolescents, and young adults. However, those from older age groups should receive booster doses of the vaccine. |
---|---|
AbstractList | Vaccination is the most effective and reliable strategy for preventing the morbidity of tetanus. The aim of the study is to investigate the seroprevalence of antibodies to tetanus toxoid among healthy persons across all age groups to determine the level of vaccine-induced immunity in the population, and to identify which age group should be targeted for a booster dose.
A total of 2,842 serum samples collected between 2010 - 2019 from individuals aged from 1 month - 97 years were investigated. Anti-tetanus IgG antibody concentrations (IU/ml) were measured by an enzyme-linked immunosorbent assay. In addition, the avidity of antibodies was determined using an in-house ELISA.
The results showed that among the 2,842 individuals, 147 (5.2%) had anti-tetanus toxoid IgG antibody levels below 0.1 IU/ml and another 1,519 (53.4%) subjects showed only basic protection (0.1-1.0 IU/ml) and needed immediate booster. High levels of anti-tetanus toxoid IgG antibodies (>1.0 IU/ml) were found more often in young adults at the age 21-40 years (55.5%, GMT=1.15). Importantly, these antibodies also had the highest avidity. With age, the percentage of high positives decreased, as well as the geometric mean and avidity of antibodies, reaching the lowest level in subjects over 70 years of age (13.3%; GMT=0.19). Characteristically, a higher percentage of high positive results was observed in men (42.6%) than in women (34.3%).
The study showed adequate immunity levels to tetanus amongst the Polish population, especially in children, adolescents, and young adults. However, those from older age groups should receive booster doses of the vaccine. Vaccination is the most effective and reliable strategy for preventing the morbidity of tetanus. The aim of the study is to investigate the seroprevalence of antibodies to tetanus toxoid among healthy persons across all age groups to determine the level of vaccine-induced immunity in the population, and to identify which age group should be targeted for a booster dose.INTRODUCTION AND OBJECTIVEVaccination is the most effective and reliable strategy for preventing the morbidity of tetanus. The aim of the study is to investigate the seroprevalence of antibodies to tetanus toxoid among healthy persons across all age groups to determine the level of vaccine-induced immunity in the population, and to identify which age group should be targeted for a booster dose.A total of 2,842 serum samples collected between 2010 - 2019 from individuals aged from 1 month - 97 years were investigated. Anti-tetanus IgG antibody concentrations (IU/ml) were measured by an enzyme-linked immunosorbent assay. In addition, the avidity of antibodies was determined using an in-house ELISA.MATERIAL AND METHODSA total of 2,842 serum samples collected between 2010 - 2019 from individuals aged from 1 month - 97 years were investigated. Anti-tetanus IgG antibody concentrations (IU/ml) were measured by an enzyme-linked immunosorbent assay. In addition, the avidity of antibodies was determined using an in-house ELISA.The results showed that among the 2,842 individuals, 147 (5.2%) had anti-tetanus toxoid IgG antibody levels below 0.1 IU/ml and another 1,519 (53.4%) subjects showed only basic protection (0.1-1.0 IU/ml) and needed immediate booster. High levels of anti-tetanus toxoid IgG antibodies (>1.0 IU/ml) were found more often in young adults at the age 21-40 years (55.5%, GMT=1.15). Importantly, these antibodies also had the highest avidity. With age, the percentage of high positives decreased, as well as the geometric mean and avidity of antibodies, reaching the lowest level in subjects over 70 years of age (13.3%; GMT=0.19). Characteristically, a higher percentage of high positive results was observed in men (42.6%) than in women (34.3%).RESULTSThe results showed that among the 2,842 individuals, 147 (5.2%) had anti-tetanus toxoid IgG antibody levels below 0.1 IU/ml and another 1,519 (53.4%) subjects showed only basic protection (0.1-1.0 IU/ml) and needed immediate booster. High levels of anti-tetanus toxoid IgG antibodies (>1.0 IU/ml) were found more often in young adults at the age 21-40 years (55.5%, GMT=1.15). Importantly, these antibodies also had the highest avidity. With age, the percentage of high positives decreased, as well as the geometric mean and avidity of antibodies, reaching the lowest level in subjects over 70 years of age (13.3%; GMT=0.19). Characteristically, a higher percentage of high positive results was observed in men (42.6%) than in women (34.3%).The study showed adequate immunity levels to tetanus amongst the Polish population, especially in children, adolescents, and young adults. However, those from older age groups should receive booster doses of the vaccine.CONCLUSIONSThe study showed adequate immunity levels to tetanus amongst the Polish population, especially in children, adolescents, and young adults. However, those from older age groups should receive booster doses of the vaccine. |
Author | Śmietańska, Karolina Rastawicki, Waldemar |
Author_xml | – sequence: 1 givenname: Karolina orcidid: 0000-0002-7205-971X surname: Śmietańska fullname: Śmietańska, Karolina – sequence: 2 givenname: Waldemar orcidid: 0000-0002-3301-8632 surname: Rastawicki fullname: Rastawicki, Waldemar |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39344719$$D View this record in MEDLINE/PubMed |
BookMark | eNo90EtLxDAQwPEgK-5Db54lRw_WzaOP9CiLrgsLCupNKNN0Uiptsiat6Le3uqunmcOPYfjPycQ6i4Scc3Yt0jiOlwDYLbkSucqOyIyrXEVCpHIy7kKKiOdpOiXzEN4YEypR_IRMZS7jOOP5jLw-oXc7jx_QotVInaGbek3B9k3pqgYDhRoaG3raYw92CLR3n66pKHTO1rRqjEGPth8Z0tq7YRdoY-mja8FWp-TYQBvw7DAX5OXu9nl1H20f1pvVzTbSQqV9JMBwk2bIWFZyQKUlaKZZgkrqvMx1BZKzpAKD2ugSQKACmas4rtI0S3QpF-Ryf3fn3fuAoS-6Jmhsxx_QDaGQnHPBhFBqpBcHOpQdVsXONx34r-KvyAiu9kB7F4JH8084K36DFz_Bi31w-Q1nknTc |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.26444/aaem/182987 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1898-2263 |
EndPage | 333 |
ExternalDocumentID | 39344719 10_26444_aaem_182987 |
Genre | Journal Article |
GeographicLocations | Poland |
GeographicLocations_xml | – name: Poland |
GroupedDBID | --- 23M 2WC 53G 5GY 5VS 7RV 8FI AAYXX ABUWG ADBBV AENEX AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS BAWUL BBNVY BCNDV BENPR BHPHI CITATION E3Z EN8 F5P FYUFA GROUPED_DOAJ HCIFZ KQ8 M7P NAPCQ OK1 OVT P2P P6G PIMPY RNS TR2 UKHRP XSB Y2W CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c286t-2af1f67e007b1ae8c3ac0c05e83c9b9cda3105dafecfcbaa2e8a39844d6675cb3 |
ISSN | 1232-1966 1898-2263 |
IngestDate | Fri Sep 05 06:15:59 EDT 2025 Mon Jul 21 05:40:42 EDT 2025 Tue Jul 01 02:59:14 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | IgG antibodies tetanus tetanus toxoid vaccination |
Language | English |
License | https://creativecommons.org/licenses/by-nc/3.0/pl/deed.en |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c286t-2af1f67e007b1ae8c3ac0c05e83c9b9cda3105dafecfcbaa2e8a39844d6675cb3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-3301-8632 0000-0002-7205-971X |
OpenAccessLink | https://www.aaem.pl/pdf-182987-104893?filename=Seroprevalence of IgG.pdf |
PMID | 39344719 |
PQID | 3111202288 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_3111202288 pubmed_primary_39344719 crossref_primary_10_26444_aaem_182987 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-Sep-25 |
PublicationDateYYYYMMDD | 2024-09-25 |
PublicationDate_xml | – month: 09 year: 2024 text: 2024-Sep-25 day: 25 |
PublicationDecade | 2020 |
PublicationPlace | Poland |
PublicationPlace_xml | – name: Poland |
PublicationTitle | Annals of Agricultural and Environmental Medicine |
PublicationTitleAlternate | Ann Agric Environ Med |
PublicationYear | 2024 |
SSID | ssj0028581 |
Score | 2.3591042 |
Snippet | Vaccination is the most effective and reliable strategy for preventing the morbidity of tetanus. The aim of the study is to investigate the seroprevalence of... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database |
StartPage | 329 |
SubjectTerms | Adolescent Adult Age Factors Aged Aged, 80 and over Antibodies, Bacterial - blood Child Child, Preschool Female Humans Immunoglobulin G - blood Infant Male Middle Aged Poland - epidemiology Seroepidemiologic Studies Tetanus - epidemiology Tetanus - immunology Tetanus - prevention & control Tetanus Toxoid - administration & dosage Tetanus Toxoid - immunology Vaccination - statistics & numerical data Young Adult |
Title | Seroprevalence of IgG antibodies against tetanus toxoid among different age groups in Poland |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39344719 https://www.proquest.com/docview/3111202288 |
Volume | 31 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZZB6UvY_dmNzRYnoLbWJYd-TGUbmVjY4OW9WHgSbIczBa7JA6U_vqdI8mXjBW2vRhjJxKc7_PROdK5EPKGwxJXKJEHSaLAQWEmDsDKnwfgGqQJNnaYccx3_vgpObvg7y_jy9Ho-yBqaduoI33zx7yS_0EVngGumCX7D8h2g8IDuAd84QoIw_WvMIYPHZuYwJD2-8SskOW7KciqVDVGB07lEhz_TTNtDNiAWyzmcF2Xue8w1PZGaaYYt2PTO2xw7Ofat_XorNa-yvJiue6LdeCe-2mfKOezfIcn9ZOTeJIuViVMj7eCb360KWi2WVB_ygRGKjZ1t7EFX-XP3KzkergjwTiGT7js5SPjtKhIASjmNZdXs17Zl0Mv3OrMyG15_K7L0VLjuFJJs8LtBcFStzQPgL1aWWSjFOsWetW7Wz27fXWH3GXgSGBzjw9funMmJmIRunQIO90xTnbspjog--2fd22WWxwRa5Cc3yf3vCdBF44WD8jIVA_JfovAI_Jtlx20Liiwg_bsoJ4d1LODOnZQyw7asQN-ZqhjBy0r6tjxmFy8PT0_OQt8L41AM5E0AZNFWCRzAyahCqUROpJ6pmexEZFOVapzCXZ-nMvC6EIrKZkRMkoF53kCLqVW0ROyV9WVOSQU0J3pmCtQ_RKMbS3DeVgonufzNInDuRyTSSut7MqVTMnA1bQCzlDAmRPwmLxuRZmBTsODKlmZervJIliAGRZmEmPy1Mm4G6nF5Nmtb56Tg56VL8hes96al2A5NuqVBf8XrDdxDw |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Seroprevalence+of+IgG+antibodies+against+tetanus+toxoid+among+different+age+groups+in+Poland&rft.jtitle=Annals+of+Agricultural+and+Environmental+Medicine&rft.au=%C5%9Amieta%C5%84ska%2C+Karolina&rft.au=Rastawicki%2C+Waldemar&rft.date=2024-09-25&rft.eissn=1898-2263&rft.volume=31&rft.issue=3&rft.spage=329&rft_id=info:doi/10.26444%2Faaem%2F182987&rft_id=info%3Apmid%2F39344719&rft.externalDocID=39344719 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1232-1966&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1232-1966&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1232-1966&client=summon |